Headline News about Merck & Co
Immutep Issues Development Update For Its Lead Cancer Candidate
September 14, 2022
Via Benzinga
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
Via Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
September 13, 2022
Via Benzinga
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
September 13, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|